CD112+ and CD155+ macrophages were more frequently expressed in NSCLC aspirates, and with a trend also in PC aspirates, while the third TIGIT ligand, PVRL4, was in the majority expressed by macrophages from BC and PC aspirates. This evidence concerns the gene NECTIN4 and breast cancer.